![](https://partners4access.com/wp-content/uploads/2022/09/french-flag-g8f9865716_1280-300x200.png)
HAS Changes its Criteria for Pharmacoeconomic Evaluation
By Priyanka Kiritharan, Analyst Email: [email protected] Last month, France’s HTA body; Haute Autorite De Sante (HAS) changed its criteria that triggers the cost-effectiveness evaluation of products